- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04803682
A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths
ASPIRE+ Mentoring Moon Shot Youth Lung Prevention
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
PRIMARY OBJECTIVES:
I. To evaluate the feasibility of training selected eleventh grade high school student volunteers to provide an intervention involving mentoring combined with social support activities.
II. To increase ninth grade high school student well-being, which would ultimately influence tobacco related knowledge and resistance skills regarding tobacco uptake among ninth grade high school program participants.
EXPLORATORY OBJECTIVES:
I. Mentor ability, confidence, and intention (ACI) to address tobacco use and dependence and providing anti-tobacco advice to mentees.
II. To determine the scores on mentoring competencies. III. To determine the influences of social support and self-esteem by mentors. IV. To determine the quality and satisfaction with the relationships among mentors and mentees.
V. To determine level of knowledge about nicotine and tobacco products among mentees.
VI. To determine susceptibility to tobacco use among non-smokers. VII. To determine progression through stages of change among smokers.
OUTLINE:
Participants complete online ASPIRE course over 3.5-4 hours.
HIGH SCHOOL MENTORS: Eleventh grade high school students receive mentor training over 4-5 hours on how to mentor ninth grade students.
ALL STUDENTS: Mentors and mentees are paired up so that eleventh grade high school students mentor the ninth grade high school students over 30 minutes for 7 sessions about the different types of tobacco products (such as cigarettes, cigars, hookah, and so on) and the dangers of these products.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase temprana 1
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- M D Anderson Cancer Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Ages 13-18
- Enrolled in grades nine or eleven
- Speaks and understands English
- Parent or legally authorized guardian (LAR) provide written consent for study participation
- Student provides written assent for study participation
Exclusion Criteria
- Unable to speak and understand English
- Lives in the same household with another participant in the study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Prevention (ASPIRE, mentorship)
Participants complete online ASPIRE course over 3.5-4 hours. HIGH SCHOOL MENTORS: Eleventh grade high school students receive mentor training over 4-5 hours on how to mentor ninth grade students. ALL STUDENTS: Mentors and mentees are paired up so that eleventh grade high school students mentor the ninth grade high school students over 30 minutes for 7 sessions about the different types of tobacco products (such as cigarettes, cigars, hookah, and so on) and the dangers of these products. |
Participate in ASPIRE and mentorship program
Otros nombres:
Ancillary studies (pre and post questionnaire)
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Required number of participants should be 40 mentors and 100 mentees
Periodo de tiempo: 3 years
|
At least 40 mentors and 100 mentees.
|
3 years
|
|
Number of participants required to complete baseline and post-intervention assessments should be 35 mentors and 80 mentees
Periodo de tiempo: 3 years
|
At least 80% completion rates.
|
3 years
|
|
All participants are required to attend at least 5 of 7 sessions of mentor to mentees interactions
Periodo de tiempo: 3 years
|
At least 5 of 7 sessions of mentor/mentee interactions
|
3 years
|
|
Participants with the ability to provide the level of satisfaction with the program
Periodo de tiempo: 3 years
|
Training program for mentors and overall program satisfaction.
Seventeen-item rating scale (1 = not skilled at all to 7 = extremely skilled) about facets of mentoring.
|
3 years
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Tobacco related knowledge among mentees
Periodo de tiempo: 3 years
|
Assessed by comparing pre and post intervention scores.
Three-item rating scale (0 = no ability/confidence/intention to 4 = high ability, confidence, and intention) Nineteen-item scale measuring quality of mentor to mentee relationship.
Four point Likert scale (1 = not true at all to 4 = very true) Twenty-five item scale.
Multiple choice questions to measure tobacco and nicotine product knowledge developed by ASPIRE study team
|
3 years
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Alexander V Prokhorov, M.D. Anderson Cancer Center
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 2015-0258 (Otro identificador: M D Anderson Cancer Center)
- NCI-2019-02481 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .